WallStreetZenWallStreetZen

NASDAQ: ACRV
Acrivon Therapeutics Inc Stock Ownership - Who owns Acrivon Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Acrivon Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter BlumejensenPresident and CEO2025-05-2119,904$1.15
$22.89kSell
Eric DevroeChief Operating Officer2025-05-14613$1.14
$698.82Sell
Erick GamelinChief Development Officer2025-05-14403$1.14
$459.42Sell
Peter BlumejensenPresident and CEO2025-05-1459,766$1.14
$68.13kSell
Peter BlumejensenPresident and CEO2025-05-14491$1.14
$559.74Sell
Katharine PetersonChief Accounting Officer2025-05-1499$1.14
$112.86Sell
Mary MillerChief Legal Officer2025-05-14184$1.14
$209.76Sell
Perceptive Advisors LLC10% Owner2025-05-01298,886$1.34
$400.51kSell
Perceptive Advisors LLC10% Owner2025-04-30437,881$1.41
$617.41kSell
Perceptive Advisors LLC10% Owner2025-04-29250,000$1.41
$352.50kSell

1 of 5

ACRV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRV insiders and whales buy or sell their stock.

ACRV Shareholders

What type of owners hold Acrivon Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP26.60%8,340,508$10.01MInstitution
Perceptive Advisors LLC17.10%5,360,858$6.43MInstitution
Chione Ltd12.27%3,848,632$4.62MInsider
Kristina Masson11.77%3,691,232$4.43MInsider
Perceptive Advisors LLC9.90%3,104,139$3.72MInsider
Peter Blumejensen8.98%2,815,795$3.38MInsider
Sands Capital Ventures LLC6.77%2,122,605$2.55MInstitution
Citadel Advisors LLC6.05%1,895,519$2.27MInstitution
Blackrock Inc2.99%938,707$1.13MInstitution
Wellington Biomedical Innovation Master Investors Cayman I LP2.83%888,130$1.07MInsider

1 of 3

ACRV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRV60.12%39.88%Net SellingNet Selling
JUNS1.14%0.10%
KPTI9.36%90.64%Net SellingNet Selling
CLNN1.16%98.84%Net BuyingNet Selling
BRNS23.51%54.05%
View Top Biotech Stocks

Acrivon Therapeutics Stock Ownership FAQ

Who owns Acrivon Therapeutics?

Acrivon Therapeutics (NASDAQ: ACRV) is owned by 71.81% institutional shareholders, 47.64% Acrivon Therapeutics insiders, and 0.00% retail investors. Chione Ltd is the largest individual Acrivon Therapeutics shareholder, owning 3.85M shares representing 12.27% of the company. Chione Ltd's Acrivon Therapeutics shares are currently valued at $4.62M.

If you're new to stock investing, here's how to buy Acrivon Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.